# Perimenopause and metabolic health: which numbers add useful context?

Glucose, blood pressure and cholesterol answer different questions when body composition changes in midlife.

Canonical: https://velri.co/blog/perimenopause-insulin-resistance-weight-biomarkers-strength-seeker
Publisher: Velri (https://velri.co/about)
Published: 2026-06-29
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

A changing waistline during perimenopause can prompt a useful metabolic-health review. It does not, by itself, diagnose insulin resistance. Blood glucose, blood pressure and cholesterol each add different information. [1][2][3]

## Glucose: is blood sugar regulation changing?

A1c, fasting plasma glucose and an oral glucose tolerance test can assess prediabetes. NIDDK notes that insulin resistance and prediabetes often have no symptoms, and that direct tests of insulin resistance are mainly used in research. [1]

A glucose assessment can therefore be informative even when someone feels well.

## Blood pressure and cholesterol: a broader risk picture

High blood pressure commonly causes no symptoms. Measuring it addresses a risk factor that a hormone panel does not measure. [2]

A lipid panel reports different components, including LDL cholesterol, HDL cholesterol and triglycerides. The results are interpreted alongside other cardiovascular risk factors including blood pressure, smoking and family history. [3]

## Put body composition beside the lab results

The SWAN study found faster fat gain and declining lean mass during the menopause transition, without an equivalent acceleration in total weight gain. Because this was observational research, it describes a population pattern rather than proving why an individual’s body changed. [4]

That is a reason to read the scale alongside health measures and physical function. The goal is to identify changes that matter to health and follow-up.

A useful follow-up comparison keeps the question consistent: which result changed, under what circumstances, and does it alter the assessment?

## Sources
[1] Insulin Resistance & Prediabetes - NIDDK (2025). https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance
[2] About High Blood Pressure | High Blood Pressure | CDC (2026). https://www.cdc.gov/high-blood-pressure/about/index.html
[3] Cholesterol Levels: MedlinePlus Medical Test (2025). https://medlineplus.gov/lab-tests/cholesterol-levels/
[4] Changes in body composition and weight during the menopause transition. (2019). https://pubmed.ncbi.nlm.nih.gov/30843880/

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support